1
|
Widiatmoko A, Fitri LE, Endharti AT, Murlistyarini S, Brahmanti H, Yuniaswan AP, Ekasari DP, Rasyidi F, Nahlia NL, Safitri PR. Inhibition Effect of Physalis angulata Leaf Extract on Viability, Collagen Type I, and Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) but Not Plasminogen Activator Inhibitor-1 (PAI-1) of Keloid Fibroblast Culture. Clin Cosmet Investig Dermatol 2023; 16:2365-2373. [PMID: 37667736 PMCID: PMC10475283 DOI: 10.2147/ccid.s425036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Accepted: 08/11/2023] [Indexed: 09/06/2023]
Abstract
Introduction Keloids are excessive fibroproliferative diseases that are caused by abnormal wound healing. The anti-proliferative activity of Physalis angulata compounds has potential as a keloid therapeutic agent. This study aimed to observe the effects of P. angulata on fibroblast viability and collagen type I, tissue inhibitor of metalloproteinase 1 (TIMP-1), and plasminogen activator inhibitor 1 (PAI-1) levels in human keloid fibroblasts. Methods We conducted an experimental study of P. angulata ethanol extract on three primary human keloid fibroblast 3 passage cultures with four replications. Fibroblast viability was measured using the MTT assay after incubation with 3, 5, and 10 µg/mL P. angulata. Concentrations of P. angulata used to observe effects on TIMP-1, PAI-1, and collagen type I levels were 10%, 20%, 30%, and 40% of inhibitory concentration 50 (IC50). The levels of collagen type I, TIMP-1, and PAI-1 were measured by ELISA. Mean comparisons between multiple treatment groups were analyzed using one-way ANOVA followed by post-hoc analysis. Results The 10 µg/mL P. angulata group had significantly lower fibroblast viability than the control group (p<0.05) with an IC50 6.3 µg/mL. The collagen type I level of 10% IC50 (0.63 µg/mL) P. angulata group was lower than control (12.910 vs 47.866 ng/mL) (p=0.042). Level of TIMP-1 in 40% IC50 (2.51 µg/mL) P. angulata group was lower than control (5.350 vs 9.972 ng/mL) (p=0.043). There was no significant difference in the PAI-1 levels. Conclusion This study showed the inhibitory effect of 10 µg/mL P. angulata extract on keloid fibroblast viability, with an IC50 of 6.3 µg/mL. This study also showed collagen type-1 and TIMP-1 inhibition, but not PAI-1 inhibition, after P. angulate treatment.
Collapse
Affiliation(s)
- Arif Widiatmoko
- Doctoral Program in Medical Science, Faculty of Medicine Universitas Brawijaya, Malang, East Java, Indonesia
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| | - Loeki Enggar Fitri
- Doctoral Program in Medical Science, Faculty of Medicine Universitas Brawijaya, Malang, East Java, Indonesia
- Department of Parasitology, Faculty of Medicine Universitas Brawijaya, Malang, East Java, Indonesia
| | - Agustina Tri Endharti
- Doctoral Program in Medical Science, Faculty of Medicine Universitas Brawijaya, Malang, East Java, Indonesia
- Department of Parasitology, Faculty of Medicine Universitas Brawijaya, Malang, East Java, Indonesia
| | - Sinta Murlistyarini
- Doctoral Program in Medical Science, Faculty of Medicine Universitas Brawijaya, Malang, East Java, Indonesia
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| | - Herwinda Brahmanti
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| | - Anggun Putri Yuniaswan
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| | - Dhany Prafita Ekasari
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| | - Faradiani Rasyidi
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| | - Nurul Laili Nahlia
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| | - Putri Rachma Safitri
- Department of Dermatology and Venereology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia
| |
Collapse
|